PL364914A1 - T cell receptor vbeta-dbeta-jbeta sequence and methods for its detection - Google Patents

T cell receptor vbeta-dbeta-jbeta sequence and methods for its detection

Info

Publication number
PL364914A1
PL364914A1 PL00364914A PL36491400A PL364914A1 PL 364914 A1 PL364914 A1 PL 364914A1 PL 00364914 A PL00364914 A PL 00364914A PL 36491400 A PL36491400 A PL 36491400A PL 364914 A1 PL364914 A1 PL 364914A1
Authority
PL
Poland
Prior art keywords
jbeta
dbeta
sequence
detection
methods
Prior art date
Application number
PL00364914A
Other languages
Polish (pl)
Inventor
Jingwu Z. Zhang
Original Assignee
Baylor College Of Medicine
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baylor College Of Medicine filed Critical Baylor College Of Medicine
Publication of PL364914A1 publication Critical patent/PL364914A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/7051—T-cell receptor (TcR)-CD3 complex
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Neurology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Neurosurgery (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Endocrinology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Cell Biology (AREA)
  • Emergency Medicine (AREA)
  • Ophthalmology & Optometry (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Hematology (AREA)
  • Hospice & Palliative Care (AREA)
  • Obesity (AREA)
PL00364914A 2000-08-22 2000-08-22 T cell receptor vbeta-dbeta-jbeta sequence and methods for its detection PL364914A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2000/022988 WO2002016434A1 (en) 2000-08-22 2000-08-22 T CELL RECEPTOR Vβ-Dβ-Jβ SEQUENCE AND METHODS FOR ITS DETECTION

Publications (1)

Publication Number Publication Date
PL364914A1 true PL364914A1 (en) 2004-12-27

Family

ID=21741700

Family Applications (1)

Application Number Title Priority Date Filing Date
PL00364914A PL364914A1 (en) 2000-08-22 2000-08-22 T cell receptor vbeta-dbeta-jbeta sequence and methods for its detection

Country Status (12)

Country Link
EP (1) EP1311543A1 (en)
JP (1) JP2004506743A (en)
KR (1) KR20030086983A (en)
CN (1) CN1505640A (en)
AU (1) AU2000269239A1 (en)
BR (1) BR0017319A (en)
CA (1) CA2420283A1 (en)
HU (1) HUP0400499A2 (en)
IL (2) IL154544A0 (en)
MX (1) MXPA03001569A (en)
PL (1) PL364914A1 (en)
WO (1) WO2002016434A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7658926B2 (en) 2001-09-14 2010-02-09 Opexa Pharmaceuticals, Inc. Autologous T-cell vaccines materials and methods
ES2537951T3 (en) 2002-08-08 2015-06-16 Baylor College Of Medicine Isolation and identification of T cells
AU2003902299A0 (en) * 2003-05-13 2003-05-29 Flinders Medical Centre A method of analysing a marker nucleic acid molecule
WO2008131599A1 (en) * 2007-04-30 2008-11-06 Maxx Genetech Co., Ltd. T-cell receptor vaccines materials and methods
CN102875667B (en) * 2012-09-05 2014-07-09 南方医科大学 HIV-1 (human immunodeficiency virus-1) peptide Env120-128 specificity TCR (T cell receptor), recombinant retroviral vector thereof and application
CN102875666B (en) * 2012-09-05 2014-07-09 南方医科大学 Tuberculosis antigen specificity TCR (T cell receptor), recombinant retroviral vector thereof and application

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1355852A (en) * 1999-02-23 2002-06-26 贝勒医学院 T cell receptor Vbeta-Dbeta-Jbeta sequence and methods for its detection

Also Published As

Publication number Publication date
IL154544A (en) 2010-05-31
WO2002016434A9 (en) 2003-10-09
JP2004506743A (en) 2004-03-04
IL154544A0 (en) 2003-09-17
AU2000269239A1 (en) 2002-03-04
CN1505640A (en) 2004-06-16
HUP0400499A2 (en) 2004-06-28
CA2420283A1 (en) 2002-02-28
WO2002016434A1 (en) 2002-02-28
MXPA03001569A (en) 2004-12-13
BR0017319A (en) 2004-01-13
EP1311543A1 (en) 2003-05-21
KR20030086983A (en) 2003-11-12

Similar Documents

Publication Publication Date Title
GB2369428B (en) Detection system
AU5083101A (en) Personal locatiom detection system
EP1304568A4 (en) Flaw detection system
HK1087436A1 (en) Fragmentation-based methods for sequence variation detection and discovery
GB2367660B (en) Methods and apparatus for automatic page break detection
EP1120846A4 (en) Cell and cell inspecting method
GB0016988D0 (en) Optical detection and analysis
GB0031049D0 (en) Methods for conducting assays and device for use therein
IL156038A0 (en) Method and system for conducting fully antomated survey research
IL154544A0 (en) T CELL RECEPTOR Vbeta-Dbeta-Jbeta SEQUENCE AND METHODS FOR ITS DETECTION
GB9907687D0 (en) Assays methods and means
GB0020363D0 (en) Detector asssemblies and methods
GB9903500D0 (en) Detection apparatus
EP1347291A4 (en) Flaw detector
MXPA03004700A (en) Methods and cells for detecting modulators of rgs proteins.
GB2372810B (en) Support and method for cell based assays
GB9918839D0 (en) Sensor devices and analytical methods for their use
GB0019146D0 (en) Gas detection device
GB2348701B (en) Assays,methods and means
GB9902087D0 (en) Detection means
AU140375S (en) Gas detection device
GB0010191D0 (en) Assays, methods and means
AU2002220180A1 (en) Energy detection and measurement system, device and methods therefor
IL150268A0 (en) Method and system for detecting radiation
GB9905671D0 (en) Sample tester

Legal Events

Date Code Title Description
REFS Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)